| 翻訳と辞書 |
Eric Ding
Eric L. Ding (born 1983 in Shanghai) is an American public health scientist in nutrition and epidemiology, a faculty at Harvard School of Public Health, founder of the ''Campaign for Cancer Prevention'', Director of Epidemiology with Microclinic International, a WEF Global Shaper, and a Soros Fellow.〔(Paul and Daisy Soros Foundation )〕
Ding was recognized in the New York Times〔(New York Times. Studies Find Higher Rates of Heart Risk With Vioxx. September 13, 2006 )〕 as a whistle-blower in the Vioxx controversy surrounding the drug safety and risks of Vioxx®, Celebrex®, and Bextra®, and founded the a large online initiative to fund and accelerate medical research.〔(A Web Campaign for Cancer Prevention. December 8, 2011 )〕 He also writes as a contributor for The Huffington Post.〔(Eric Ding on Huffington Post )〕
==Early life and education==
Ding was born in Shanghai, China, and was raised in the United States. He is an alum of the Pennsylvania Governor's School for Health Care.〔(Pennsylvania Governor's School )〕 As a child, doctors discovered that he had developed a baseball-size tumor in his chest. His initial prognosis was for less than 5 years life,〔(A Web Campaign for Cancer Prevention. December 8, 2011 )〕 but he survived.
Ding attended The Johns Hopkins University, graduating with Honors in Public Health and ''Phi Beta Kappa''. He earned his dual doctorate in epidemiology, doctorate in nutrition, and doctoral minor in biostatistics, from Harvard at age 23. He then completed his postdoctoral fellowship in Nutrition at the Harvard School of Public Health. At Harvard, has lectured in 2 dozen courses public health and clinical research, and has received the Derek Bok Distinction in Teaching Award from Harvard College. He once attended Boston University School of Medicine, but did not receive a degree.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Eric Ding」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|